Sex Differences in the effecTs of brEaking uP Sedentary Behavior on vascUlar Function in Type 2 Diabetes

NCT ID: NCT05838586

Last Updated: 2025-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-31

Study Completion Date

2025-08-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Type 2 diabetes (T2D) confers a high risk of cardiovascular disease (CVD), particularly among older adults who tend to be physically inactive. Prolonged sedentary behavior (SB) has been shown to negatively influence markers of cardiovascular risk (e.g., blood glucose, blood pressure), even among individuals who are physically active. Most studies that have examined the effects of breaking up SB have focused on young healthy males and prioritized glycemic outcomes. Additionally, sex differences in these outcomes have not been adequately examined. The present study will address these gaps. This 3-arm crossover randomized controlled trial will compare the effects of 3 SB conditions on markers of vascular function. The 3 conditions are: 1) 4 hours of prolonged SB, 2) 4 hours of SB broken up by 5 minutes of self-paced walking every hour, and 3) 4 hours of SB with one 20-minute bout of self-paced walking. In addition to examining the overall effects of each condition, sex differences in physiological responses will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will complete three interventions in a randomized order, separated by \>=6 and \<90 days. The interventions are:

1. 4 hours of prolonged SB (control, CON)
2. 4 hours of SB broken up by 5 minutes of self-paced walking every hour (BREAK)
3. 4 hours of SB with one 20-minute bout of self-paced walking (BOUT)
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CON

Control group

Group Type EXPERIMENTAL

prolonged SB

Intervention Type BEHAVIORAL

4 hours of prolonged SB

Break

Group Type EXPERIMENTAL

SB broken 1

Intervention Type BEHAVIORAL

4 hours of SB broken up by 5 minutes of self-paced walking every hour

BOUT

Group Type EXPERIMENTAL

SB broken 2

Intervention Type BEHAVIORAL

4 hours of SB with one 20-minute bout of self-paced walking

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

prolonged SB

4 hours of prolonged SB

Intervention Type BEHAVIORAL

SB broken 1

4 hours of SB broken up by 5 minutes of self-paced walking every hour

Intervention Type BEHAVIORAL

SB broken 2

4 hours of SB with one 20-minute bout of self-paced walking

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥60 years
* Postmenopausal (females only, ≥12 months without a menstrual period)
* Type 2 diabetes (hemoglobin A1c ≥6.5% and/or previous diagnosis of type 2 diabetes)
* ≥6 hours/day sedentary (assessed via IPAQ)
* Willingness to abstain from food, caffeine, alcohol and exercise for \>= 24 hours, and tobacco/smoking for ≥12 hours prior to each intervention visit
* Ability to speak and read English

Exclusion Criteria

* Type 1 diabetes
* Uncontrolled hypertension (resting systolic ≥160 or diastolic ≥110 mmHg)
* Initiation of hormone therapy or change in hormone therapy dose/frequency/route of administration in the previous 3 months
* Renal dialysis
* History of deep vein thrombosis (DVT)
* Evidence of cognitive impairment that could impact ability to consent and/or participation (Mini-Cog score \<3)
* Achieving physical activity guidelines (≥150 minutes of MVPA/week, assessed via IPAQ))
* Physical impairment or disability that interferes with ability to engage in PA (e.g., severe osteoarthritis, lower extremity amputation \[other than toe(s)/partial foot\], use of a walker or wheelchair, etc.),
* Unstable medical/psychiatric condition that could impact study participation
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary O Whipple, PhD, RN, PHN

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STEP Up T2D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Training Effects on Fuel Metabolism
NCT02150889 ACTIVE_NOT_RECRUITING NA